Skip to content

Clinical trials

Terminated Hypertension, Pulmonary trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Terminated Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20104
20111
20141
20161
20172
20182
20191
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Actelion2
Bayer2
Biogen2
Gilead Sciences2
GlaxoSmithKline1
Hannover Medical School1
Heidelberg University1
Idorsia Pharmaceuticals Ltd.1
Liquidia Technologies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary22
Pulmonary Arterial Hypertension14
Cough2
Dizziness2
Dyspnea2
Familial Primary Pulmonary Hypertension2
Scleroderma, Systemic2
Syncope2
Ventricular Dysfunction, Left2
Anemia, Iron-Deficiency1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.